Summarizes a National Multiple Sclerosis Society advisory recommending a new approach to treating a relapsing-remitting form of multiple sclerosis (MS) that affects approximately two thirds of the MS population. Use of the interferons Betaseron, Avonex, and the glatiramer acetate Copaxone in treatment...
11.2. Off Label DMT in pediatric Multiple Sclerosis Almost all DMTS used in adults have been used in children off label (Makhani et al., 2009, Ismail et al., 2018, Kornbluh & Kahn, 2023, Brenton, 2022). These include interferons (Vermersch et al., 2022), glatiramer acetate, natalizumab...
graph theory; network analysis; multiple sclerosis (MS); brain connectivity; functional magnetic resonance imaging (fMRI); neuroimaging1. Introduction Multiple sclerosis (MS) is an autoimmune inflammatory disorder that occurs in the central nervous system (CNS) and, in contrast to other neurological ...
Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis. Life. 2023; 13(11):2132. https://doi.org/10.3390/life13112132 Chicago/Turabian Style Maier, Smaranda, Zoltán Bajkó, Ruxandra Roșescu, Laura Bărcuțean, Emanuela Sărmășan, Septimiu Voidăzan, and Rodic...
Multiple Sclerosis (MS) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - Medical Professional Version.
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and European Academy of Neurology (EAN) joint consensus statement on vaccination in people with multiple sclerosis provides highly relevant clinical guidance on immunization strategies in today's era of effective immunotherapie...
(Thompson et al., 2018) is the most used to reach a consensual and accurate diagnosis of multiple sclerosis. It allows an earlier diagnosis and includes specific guidelines for using MRI and cerebrospinal fluid (CSF) analysis to speed up the diagnostic process (Hurwitz, 2009;Society, 2019;...
Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America A. Gabbai et al., "Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America,"... Adriana,...
In a clinical review conducted by an international committee of multiple sclerosis (MS) experts in pediatric and adult MS and published online Sept. 16 in JAMA Neurology, consensus guidance is provided for diagnosing pediatric and late-onset MS.
Evidence-based guidelines Abstract The clinical use of MRI in patients with multiple sclerosis (MS) has advanced markedly over the past few years. Technical improvements and continuously emerging data from clinical trials and observational studies have contributed to the enhanced performance of this tool...